Revolution Medicines, Inc. revenue for the last year amounted to 11.58 M USD, the most of which — 11.58 M USD — came from its highest performing source at the moment, Novel Targeted Therapies, the year earlier bringing 35.38 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Revolution Medicines, Inc. 11.58 M USD, and the year before that — 35.38 M USD.